Past due percentage reduced from 18% to 8% within one year for a global biopharmaceutical company
Past due percentage reduced from 18% to 8% within one year for a global biopharmaceutical company
1 Pageslife science Past due percentage reduced from 18% to 8% within one year for a global biopharmaceutical company A global leader in research-based biopharmaceuticals needed to increase cash flow to its business in Poland by reducing the high percentage of past due invoices. Genpact’s solution included tools and process components that enhanced collections efficiency and produced US$3.02 million in business impact. Business challenge The OTC op
